Significance of micrometastases on the survival of women with T1 breast cancer

Cancer

Volumn 107, Issue 6, 2006, Pages 1234-1239

  Maibenco, Douglas C ^a   Dombi, George W ^b   Kau, Tsui Y ^c   Severson, Richard K ^d  

^a Surgical Specialists of Decatur   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

Breast cancer; Micrometastases; Multivariate analysis; SEER

Indexed keywords

ADULT; AGED; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL TIME; TUMOR VOLUME;

AGED; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; SEER PROGRAM; SURVIVAL ANALYSIS;

EID: 33749034180     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22112     Document Type: Review

References (31)

1. Huvos AG, Hutter RVP, Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg. 1971;173:44-46.
2. Beahrs OH, Myers MH, eds. Manual for staging of cancer, 2nd ed. Philadelphia: J.B. Lippincott, 1984.
3. Beahrs OH, Henson DE, Hutter RVP, Myers MH, eds. Manual for staging of cancer, 3rd ed. Philadelphia: J.B. Lippincott, 1988.
4. Beahrs OH, Henson DE, Hutter RVP, Myers MH, eds. Manual for staging of cancer, 4th ed. Philadelphia: J.B. Lippincott, 1992.
5. Fleming ID, Coope JS. Hensen DE, et al., eds. AJCC cancer staging manual, 5th ed. Philadelphia: Lippincott-Raven, 1998.
6. Singletary SE, Alllred C, Ashley P, Bassett LW, Berry D. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20:3628-2636.
7. Dowlatshahi K, Fan M, Snider HC. Lymph node micrometastases from breast carcinoma. Reviewing the dilemma. Cancer. 1997;80:1188-1197.
8. Gray RJ, Cox CE, Reingten DS. Importance of missed axillary micrometastases in breast cancer patients. Breast J. 2001;7:303-307.
9. Noguchi M. Sentinel lymph node biopsy and breast cancer. Br J Surg. 2002;89:21-34.
10. Weaver DL. Sentinel lymph nodes and breast carcinoma. Which micrometastases are clinically significant? Am J Surg Pathol. 2003;27:842-845.
11. Pickren JW. Significance of occult metastases. A study of breast cancer. Cancer. 1961;14:1266-1271.
12. Fisher ER, Swamidoss S, Lee CH, et al. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer. 1978;42:2025-2031.
13. Rosen PP, Saigo PE, Braun DW, et al. Axillary micro- and macrometastases in breast cancer. Prognostic significance of tumor size. Ann Surg. 1981;194:585-591.
14. Rosen PP. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol. 1989;7:1239-1251.
15. Trojani M, de Mascarel I, Bonichon F, et al. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer. 1987;55:303-306.
16. Friedman S, Bertin F, Mouriesse H, et al. Importance of tumor cells in axillary node sinus margins ('clandestine' metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncol. 1988;27:483-487.
17. International (Ludwig) Breast Cancer Study Group. Prognostic importance of axillary lymph node micrometastases from breast cancers. Lancet. 1990;335:1565-1568.
18. de Mascsarel I, Bonichon F, Coindre JM, et al. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer. 1992;66:523-527.
19. Clayton F, Hopkins CL. Pathologic correlates of prognosis in lymph node-positive breast carcinomas. Cancer. 1993;71:1780-1790.
20. Hainsworth PJ, Tjandra JJ, Stillwell RG, et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg. 1993;80:459-463.
21. Nasser IA. Occult axillary lymph node metastases in "node- negative" breast carcinoma. Hum Pathol. 1993;24:950-957.
22. McGucklin MA, Cummings MC, Walsh MD, et al. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer. 1996;73:88-95.
23. Percy C, Van Holten V, Muir C, eds. International classifica-tion of diseases for oncology, 2nd ed. Geneva: World Health Organization, 1990.
24. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53;457-481.
25. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.
26. Fisher ER, Palekar A, Rockett H, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). V. Significance of axillary nodal micro- and macrometastases. Cancer. 1978;42:2032-2038.
27. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222:394-401.
28. Wilkinson EJ, Hause LL, Hoffman RG, et al. Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases. Pathol Annu. 1982;17:67-91.
29. Clare SE, Sener SFR, Wilkens W, et al. Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol. 1997;4:447-451.
30. Wells CA, Heryet A, Brochier J, Gatter KC, Mason DY. The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer. 1984;50:193-197.
31. Clarke CA, West DW, Edwards BK, Figgs LW, Kerner J, Schwartz AG. Existing data on breast cancer in African-American women. Cancer. 2003;97(1 Suppl):211-221.